As of 2025-09-18, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (38.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -52889.7%.
The range of the Relative Valuation is (37.79) - (38.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 20.5x | 19.6x |
| Forward P/E multiples | 20.2x - 22.2x | 21.2x |
| Fair Price | (37.79) - (38.42) | (38.11) |
| Upside | -52436.3% - -53317.2% | -52889.7% |
| Date | P/E |